Sveriges mest populära poddar
Bloomberg Businessweek
NyheterNäringsliv

Bloomberg Markets: Gilead to Buy Kite for $11.9 Billion

10 min•28 augusti 2017

(Bloomberg) -- Bloomberg Markets with Carol Massar and Cory Johnson. GUEST: Asthika Goonewardene Senior Analyst:Biotech Bloomberg Intelligence Discussing Gilead Sciences Inc. agreed to buy Kite Pharma Inc. for about $11.9 billion, making one of its biggest deals ever to expand beyond its eroding hepatitis C drug franchise. 

See omnystudio.com/listener for privacy information.

Fler avsnitt av Bloomberg Businessweek

Visa alla avsnitt av Bloomberg Businessweek
VistaJet US President Leona Qi on Global Private Jet Expansion
•11 min
Bessent’s Mentor Stanley Druckenmiller Calls Bond Buying a Mistake
•41 min
Trump's Family Joins the Sprint to Get a National Bank Charter
•11 min
Bessent Warns Iran’s Trade Partners to Cut Ties or Face Sanctions
•42 min
Inside Trump's Months-Long Effort to Get His Signature on US Currency
•12 min
Bloomberg Businessweek Weekend: August 21st, 2026
•39 min
Treasury Whiplash Leaves Traders Guessing Scott Bessent's Next Move
•36 min
Texas Is the Tip of a Melting Muni Iceberg: How a 'Boycott' Led to Higher Costs
•12 min
Broadcom Seeks More Than $60 Billion in Latest AI Debt Deal
•35 min
Rocks, Lime, Concrete & Steel: Investing in AI Data Center Building Blocks
•7 min

Bloomberg Businessweek med Bloomberg finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.